Taku Kobayashi Selected Research

Taku Kobayashi Research Topics

Disease

37	Ulcerative Colitis 03/2022 - 06/2008
22	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 11/2008
19	Crohn Disease (Crohn's Disease) 01/2022 - 08/2009
18	Colitis 10/2020 - 11/2008
13	Inflammation (Inflammations) 01/2021 - 03/2010
5	Neoplasms (Cancer) 01/2022 - 01/2015
4	Infections 01/2021 - 01/2018
3	Injection Site Reaction 01/2022 - 01/2020
3	Necrosis 01/2022 - 01/2022
2	Rheumatoid Arthritis 01/2022 - 11/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 06/2020
2	Hemorrhage 01/2022 - 11/2018
2	Leukopenia 11/2021 - 09/2018
2	Ulcer 11/2018 - 10/2017
1	Herpes Zoster 03/2022
1	Genetic Risk Score 01/2022
1	Diarrhea 01/2022
1	Fever (Fevers) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Skin Neoplasms (Skin Cancer) 06/2020
1	Melanoma (Melanoma, Malignant) 06/2020
1	Pathologic Constriction (Stenosis) 06/2020
1	Abscess 11/2018
1	Measles 11/2018
1	Hepatitis B 11/2018
1	Mumps 11/2018
1	Rubella (German Measles) 11/2018
1	Virus Diseases (Viral Diseases) 11/2018
1	Chickenpox 11/2018
1	Alopecia (Baldness) 09/2018
1	Arthralgia (Joint Pain) 05/2018
1	Disease Progression 04/2018
1	Intestinal Failure 04/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2018
1	Pulmonary Tuberculosis 01/2018
1	Fistula 12/2017
1	Enteritis 10/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2017

Drug/Important Bio-Agent (IBA)

10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021 - 06/2008
9	Interleukin-10 (Interleukin 10)IBA 01/2019 - 03/2010
6	Capsules (Microcapsules)IBA 04/2021 - 09/2014
5	SteroidsIBA 01/2022 - 11/2010
5	Biological ProductsIBA 01/2022 - 01/2019
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
5	Infliximab (Remicade)FDA Link 01/2021 - 03/2016
4	2-mercaptopurineIBA 01/2022 - 09/2018
4	Immunologic Factors (Immunomodulators)IBA 01/2022 - 02/2020
4	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 01/2019
4	Adalimumab (Humira)FDA Link 01/2021 - 10/2017
4	CytokinesIBA 01/2012 - 11/2008
4	Interleukin-23 (Interleukin 23)IBA 01/2011 - 06/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2005
3	vedolizumabIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
3	Interleukin-12 (IL 12)IBA 07/2021 - 08/2012
2	Certolizumab Pegol FDA Link 01/2022 - 08/2019
2	Leucine (L-Leucine)FDA Link 01/2021 - 11/2012
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 11/2012
2	TabletsIBA 07/2020 - 01/2019
2	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 11/2010
2	EnzymesIBA 09/2018 - 08/2009
2	AntigensIBA 01/2018 - 03/2017
2	Phosphotransferases (Kinase)IBA 04/2014 - 11/2010
2	Heme Oxygenase-1IBA 04/2013 - 05/2011
2	Carbon MonoxideIBA 04/2013 - 05/2011
2	InterleukinsIBA 11/2012 - 02/2009
2	Therapeutic UsesIBA 05/2011 - 11/2008
1	Janus Kinase 1IBA 03/2022
1	GLPG0634IBA 03/2022
1	P-2 (P 2)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Diphosphates (Pyrophosphates)IBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	NucleotidesIBA 11/2021
1	tofacitinibIBA 07/2021
1	Janus Kinase InhibitorsIBA 07/2021
1	Ustekinumab (CNTO 1275)FDA Link 07/2021
1	Monoclonal AntibodiesIBA 07/2021
1	AdrenomedullinIBA 01/2021
1	CT-P13IBA 10/2019
1	Biosimilar PharmaceuticalsIBA 10/2019
1	Tumor Necrosis Factor InhibitorsIBA 08/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2019
1	Cytochrome P-450 CYP3AIBA 04/2019
1	MucinsIBA 11/2018
1	VaccinesIBA 11/2018
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 11/2018
1	cysteinylcysteineIBA 09/2018
1	Codon (Codons)IBA 09/2018
1	arginylarginine (Arg-Arg)IBA 09/2018

Therapy/Procedure

19	Therapeutics 03/2022 - 05/2014
3	Remission Induction 01/2022 - 01/2017
2	Restorative Proctocolectomy 10/2020 - 05/2014
2	Colectomy 04/2018 - 11/2010
1	Duration of Therapy 01/2022
1	Drug Tapering 07/2021